Biovian
3P Biopharmaceuticals is a global Contract Development and Manufacturing Organization (CDMO) specializing in process development and cGMP manufacturing of biologics and cell therapy products. They support their clients from early-stage development to commercialization, with extensive experience in process and analytical methods development, process scale-up, GMP manufacturing, and commercial supply. Their manufacturing sites are located in Pamplona-Noáin, Spain, and Turku, Finland, meeting diverse client needs. The company is committed to making advanced biologics and life-transforming therapies, working in harmony with partners, and contributing to society through innovative solutions in biologics and regenerative medicine.
Industries
Nr. of Employees
medium (51-250)
Products
One-Stop-Shop CDMO Services
Comprehensive services in GMP manufacturing of biopharmaceuticals, covering the entire supply and value chain from early development to commercial supply.
Viral Vector Production
Development and GMP manufacturing of viral vectors, including oncolytic viruses, gene therapy vectors, and viral vector vaccines.
Adenovirus Vector Production
GMP production of adenovirus vectors for gene therapy, including process development, upstream and downstream processing, and quality control.
AAV Vector Production
GMP production of adeno-associated virus (AAV) vectors, including process development, upstream and downstream processing, and quality control.
Microbial Production
Development and GMP manufacturing of microbial products, including recombinant proteins, protein complexes, plasmid DNA, and vaccines.
Plasmid DNA Production
GMP production of plasmid DNA for viral vector manufacturing, DNA/mRNA vaccines, and non-viral gene therapy applications.
One-Stop-Shop CDMO Services
Comprehensive services in GMP manufacturing of biopharmaceuticals, covering the entire supply and value chain from early development to commercial supply.
Viral Vector Production
Development and GMP manufacturing of viral vectors, including oncolytic viruses, gene therapy vectors, and viral vector vaccines.
Adenovirus Vector Production
GMP production of adenovirus vectors for gene therapy, including process development, upstream and downstream processing, and quality control.
AAV Vector Production
GMP production of adeno-associated virus (AAV) vectors, including process development, upstream and downstream processing, and quality control.
Microbial Production
Development and GMP manufacturing of microbial products, including recombinant proteins, protein complexes, plasmid DNA, and vaccines.
Plasmid DNA Production
GMP production of plasmid DNA for viral vector manufacturing, DNA/mRNA vaccines, and non-viral gene therapy applications.
Services
Process development and GMP manufacturing of recombinant proteins using microbial and mammalian expression systems, including scale-up and analytical support.
Upstream and downstream process development, seed stock and bank preparation, analytics, and GMP production for viral vectors intended for clinical and commercial use.
Platform production of GMP-grade plasmid DNA for use in transfection and viral vector manufacturing across preclinical to commercial stages.
Process development, cell bank generation, and GMP manufacturing services for advanced therapy medicinal products and cell therapies.
Formulation support, aseptic filling, inspection, sterility testing and packaging for clinical and commercial drug product vials.
Analytical method development, validation and routine QC testing (microbiology, bioassays, biochemistry, stability studies) to support product release and regulatory filings.
Process development and GMP manufacturing of recombinant proteins using microbial and mammalian expression systems, including scale-up and analytical support.
Upstream and downstream process development, seed stock and bank preparation, analytics, and GMP production for viral vectors intended for clinical and commercial use.
Platform production of GMP-grade plasmid DNA for use in transfection and viral vector manufacturing across preclinical to commercial stages.
Process development, cell bank generation, and GMP manufacturing services for advanced therapy medicinal products and cell therapies.
Formulation support, aseptic filling, inspection, sterility testing and packaging for clinical and commercial drug product vials.
Analytical method development, validation and routine QC testing (microbiology, bioassays, biochemistry, stability studies) to support product release and regulatory filings.
Expertise Areas
- Viral vector manufacturing and process development
- GMP production and clinical supply
- Plasmid DNA production
- Protein expression and purification
Key Technologies
- Chromatographic purification
- Tangential flow filtration (TFF)
- Single‑use bioreactors (stirred‑tank)
- Packed/fixed‑bed and microcarrier culture systems
News & Updates
Successfully extended the French Research Tax Credit (CIR) certificate for another four-year period, allowing French clients to benefit from significant R&D tax credits.
Successfully extended the French Research Tax Credit (CIR) certificate for another four-year period, allowing French clients to benefit from significant R&D tax credits.